AZD5069 Neutrophil Function Study

Clinical trial NCT01480739 · COMPLETED

Trial details

NCT number: NCT01480739
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemokine Receptor 2 (CXCR2) Antagonist

Start date: 2011-12-01
Primary completion: 2012-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.